Adjuvant therapies provide ‘incredible’ outcomes in melanoma

[Editor’s note: the original version of this story referred only to adjuvant immunotherapy rather than the use of immunotherapy and targeted therapy as adjuvant treatment for high-risk melanoma. We apologise for the inaccuracy. The article has also been edited to clarify a statement relating to improvement across tumour and stage subgroups in Keynote 054.] Adjuvant ...

Already a member?

Login to keep reading.

© 2022 the limbic